Pulmonary embolism, or PE, is a serious and sometimes life-threatening condition that occurs when a blood clot travels to the ...
In the last several years, there have been numerous advancements in the field of pulmonary hypertension as a whole, but there have been few changes in the management of children with pulmonary ...
A considerable amount of information describing the structural and functional characteristics of the pulmonary circulation during postnatal lung development exists. Features such as vascular ...
With many pulmonary arterial hypertension (PAH) patients already taking Johnson & Johnson’s Opsumit (macitentan) or United Therapeutics' Adcirca (tadalafil), J&J has been pursuing a potential ...
Patients who have heart failure with preserved ejection fraction (HFpEF) and high blood pressure in the lungs (pulmonary ...
Advanced imaging, like 4D-flow CMR, aids in understanding PA remodeling in different PH subtypes, offering non-invasive differentiation. PAH patients exhibit distinct PA flow characteristics, ...
Blood clots affect hundreds of thousands each year. How advancements in blood clot treatments may help save lives.
A 51-year-old woman experienced a life-threatening pulmonary embolism, a massive blood clot in her lungs, following months of ...
"ACC 2026: Sotatercept shows signal in CpcPH-HFpEF at lower dose" was originally created and published by Pharmaceutical ...
Mr. Simpson, a man in his late 50s had come to the office with a sprained knee. But as he told his story, it was clear that wasn’t the main ...
In patients with post- and precapillary pulmonary hypertension and heart failure with preserved ejection fraction, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results